Zobrazeno 1 - 10
of 74
pro vyhledávání: '"Robert S. Elkeles"'
Autor:
Ian F. Godsland, Tullaya Sitasuwan, Robert S. Elkeles, Lukana Preechasuk, Pochamana Phisalprapa, K. George M.M. Alberti, Nick Oliver, Chaiwat Washirasaksiri, Phunchai Charatcharoenwitthaya, Pornpoj Pramyothin, Weerachai Srivanichakorn, Desmond G. Johnston
Publikováno v:
Journal of Diabetes Investigation, Vol 10, Iss 3, Pp 771-779 (2019)
Journal of Diabetes Investigation
Journal of Diabetes Investigation
Aims/Introduction Relationships between cardiometabolic risk and glycemia have rarely been studied in people under clinical evaluation and treatment for cardiometabolic risk and with prediabetes. We investigated relationships between glycemia and car
Autor:
Robert S. Elkeles
Publikováno v:
Clinical Medicine. 20:120.1-120
Editor – Induruwa et al describe the difficulties in diagnosing Bell's palsy in their secondary care setting.[1][1] Only 40% of doctors documented other important non-stroke like symptoms; none documented changes in taste or lacrimation, key attrib
Autor:
Bharti Mackness, Judit Marsillach, Robert S. Elkeles, Ian F. Godsland, Michael D. Feher, Michael B. Rubens, Marcus D. Flather, Steve E. Humphries, Jackie Cooper, Mike Mackness
Publikováno v:
Disease markers
Disease Markers, Vol 33, Iss 2, Pp 101-112 (2012)
Disease Markers, Vol 33, Iss 2, Pp 101-112 (2012)
Objectives: To determine any association between serum paraoxonase-1 (PON1) activity, protein and coding region genetic polymorphisms and coronary artery calcification (CACS) and to determine factors which modulate serum PON1 in type 2 diabetes (T2DM
Autor:
Jonathan Valabhji, Darrell V. Pavitt, Michael S. Yee, Robert S. Elkeles, H. Terence Cook, Adam McLean, William Richmond
Publikováno v:
Atherosclerosis. 205:528-532
Familial lecithin:cholesterol acyltransferase deficiency (FLD) is a monogenic autosomal recessive condition, affecting cholesterol esterification and leads to progressive renal impairment and end-stage renal failure, probably due to the abnormal lipo
Autor:
Ian F. Godsland, Robert S. Elkeles, Michael B. Rubens, Marcus Flather, F. Nugara, Michael D. Feher
Publikováno v:
Atherosclerosis. 197:777-783
Coronary calcification score (CACS) measured by electron beam tomography is well established in the evaluation of cardiovascular risk in general populations. The PREDICT study aims to evaluate prediction of cardiovascular events by CACS in Type 2 dia
Autor:
Robert S, Elkeles, Ian F, Godsland, Michael D, Feher, Michael B, Rubens, Michael, Roughton, Fiona, Nugara, Steve E, Humphries, William, Richmond, Marcus D, Flather, Krishna, Supiah
Publikováno v:
European Heart Journal. 29:2244-2251
The PREDICT Study is a prospective cohort study designed to evaluate coronary artery calcification score (CACS) as a predictor of cardiovascular events in type 2 diabetes (T2DM).A total of 589 patients with no history of cardiovascular disease and wi
Autor:
Robert S. Elkeles, Michael D. Feher
Publikováno v:
The British Journal of Diabetes & Vascular Disease. 5:330-333
Autor:
Robert S. Elkeles, Jonathan Valabhji
Publikováno v:
The British Journal of Diabetes & Vascular Disease. 3:184-189
Lipid abnormalities in type 2 diabetes are characterised by high triglyceride concentrations, low high density lipoprotein-cholesterol concentrations, and normal total and low density lipoprotein-cholesterol (LDL-c) concentrations. LDL particles, how
Autor:
S. Richard Underwood, Alex Dunlop, Gilbert R. Thompson, Michael B. Rubens, Kirstie Gibson, Clare Neuwirth, Robert S. Elkeles
Publikováno v:
European Journal of Cardiovascular Prevention & Rehabilitation. 9:349-353
Objective To document the relationship between coronary calcification and coronary risk assessed clinically in asymptomatic patients with hypercholesterolaemia.Design Prospective observational study.Setting Health screening clinic.Patients A total of
Autor:
Jonathan Valabhji, Robert S. Elkeles
Publikováno v:
Medicine. 30:47-50
Macrovascular disease is atherosclerotic disease affecting medium and large blood vessels. It manifests clinically as acute or progressive ischaemia, affecting most commonly the coronary, cerebral, renal and lower limb vessels.